|
HS Code |
336563 |
| Chemical Name | 5-bromo-3-methyl-2-nitropyridine |
| Molecular Formula | C6H5BrN2O2 |
| Molecular Weight | 217.02 g/mol |
| Cas Number | 57830-66-9 |
| Appearance | Yellow solid |
| Melting Point | 73-76 °C |
| Solubility | Soluble in organic solvents (e.g., DMSO, DMF) |
| Purity | Typically ≥98% |
| Storage Conditions | Store at room temperature, in a tightly sealed container |
| Synonyms | 5-Bromo-3-methyl-2-nitropyridine; 2-Nitro-5-bromo-3-methylpyridine |
| Hazard Statements | Irritant, harmful if swallowed or inhaled |
| Smiles | CC1=CN=C(C=C1Br)[N+](=O)[O-] |
As an accredited 5-bromo-3-methyl-2-nitropyridine factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, sealed 25g amber glass bottle with a red hazard label displaying "5-bromo-3-methyl-2-nitropyridine" and chemical safety information. |
| Container Loading (20′ FCL) | Container Loading (20′ FCL) for 5-bromo-3-methyl-2-nitropyridine: Standard 20-foot container, securely packed, moisture-protected, clearly labeled, compliant with chemical transport regulations. |
| Shipping | 5-Bromo-3-methyl-2-nitropyridine is shipped in sealed, inert containers to prevent contamination and moisture ingress. Transport follows regulations for hazardous chemicals, ensuring proper labeling and documentation. The material is typically sent via ground or air freight, with temperature control if required, and handled by authorized carriers experienced in shipping fine chemicals. |
| Storage | **5-Bromo-3-methyl-2-nitropyridine** should be stored in a tightly sealed container, away from light, moisture, and sources of ignition. Store it in a cool, dry, and well-ventilated area, separate from incompatible materials such as strong oxidizing agents and reducing agents. Properly label the container and keep it in a designated chemical storage area with restricted access. |
| Shelf Life | 5-bromo-3-methyl-2-nitropyridine is stable under recommended storage conditions; shelf life is typically 2–3 years when tightly sealed. |
|
Purity 98%: 5-bromo-3-methyl-2-nitropyridine with purity 98% is used in pharmaceutical intermediate synthesis, where it ensures high reaction yield and reduced byproduct formation. Melting point 82°C: 5-bromo-3-methyl-2-nitropyridine with melting point 82°C is used in heterocyclic compound manufacturing, where it facilitates controlled crystallization for reproducible batch quality. Molecular weight 203.02 g/mol: 5-bromo-3-methyl-2-nitropyridine with molecular weight 203.02 g/mol is used in agrochemical active ingredient development, where accurate dosing and formulation are achieved. Particle size <10 μm: 5-bromo-3-methyl-2-nitropyridine with particle size less than 10 μm is used in fine chemical blending, where it allows uniform dispersion and enhanced reactivity in catalysts. Stability temperature up to 120°C: 5-bromo-3-methyl-2-nitropyridine with stability temperature up to 120°C is used in high-temperature organic synthesis, where the compound retains structural integrity under process conditions. Water content ≤0.5%: 5-bromo-3-methyl-2-nitropyridine with water content less than or equal to 0.5% is used in moisture-sensitive reactions, where it prevents hydrolysis and maintains product stability. |
Competitive 5-bromo-3-methyl-2-nitropyridine prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615371019725 or mail to sales7@boxa-chem.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: sales7@boxa-chem.com
Flexible payment, competitive price, premium service - Inquire now!
Chemists and research teams never stop searching for new ways to improve outcomes in both pharmaceutical and material science. Some compounds stand out, leaving an impression for their unique properties and practical value. 5-bromo-3-methyl-2-nitropyridine belongs to this rare group. While the name might sound like something straight out of a textbook, it finds real use in a world where small chemical changes can massively influence results. Over the years, this compound has earned respect for its ability to open doors when constructing specialized molecules and exploring new drug candidates.
Put it next to similar pyridine compounds—like 2,3-dibromopyridine, 3-methylpyridine, or the classic nitropyridine isomers—and you start to notice the fine details. Chemically speaking, the placement of a bromine atom on the fifth position, mixed with a methyl group at three and a nitro at two, gives this pyridine backbone a distinct reactivity. That bit of molecular choreography changes how the compound interacts when you’re scouting routes for synthesis or looking for a reliable intermediate in complex reactions.
Anyone who’s spent time in a synthesis lab knows the frustration of side products or reactions that stall. Small substitutions on a ring can cut down on these problems. With 5-bromo-3-methyl-2-nitropyridine, chemists see less of the troublesome byproducts that plague other nitropyridine derivatives, especially when building blocks for active pharmaceutical ingredients (APIs). The combination of bromine and nitro groups makes certain manipulation steps more predictable. That’s a detail that matters when a failed batch can mean wasted resources and lost time.
Let’s talk about practical use. In my time working alongside medicinal chemists and analytical experts, I’ve seen how projects can drag on for months just to find the right intermediate. Often, the breakthrough comes from choosing a compound that handles tough reaction conditions without falling apart or leading to dead ends. Scientists gravitate to 5-bromo-3-methyl-2-nitropyridine for its ease in function-specific couplings. That’s especially true in stepwise syntheses requiring cross-coupling reactions like Suzuki or Buchwald-Hartwig.
Several factors shape its reputation for reliability. Compared to unsubstituted pyridines or other nitro analogs, this compound maintains stable shelf-life and resists air or light-induced degradation, cutting down on spoilage and keeping results consistent. In practice, its finely tuned reactivity means fewer steps are necessary in custom synthesis. That makes it a favorite for research organizations short on time or production facilities looking to streamline complex multi-step pathways.
Large pharmaceutical companies and boutique research outfits both regularly pivot to intermediates like 5-bromo-3-methyl-2-nitropyridine in their pursuit of novel drugs. With new regulatory scrutiny around impurities and byproduct control, starting with a reliable intermediate matters even more. Its structure guides selective transformations, reducing unknowns in the purification steps that follow.
The nitro and bromo groups each contribute. The nitro draws electron density away from the ring, making nucleophilic substitutions in follow-up steps much less trouble. The bromine, strategic for halogenated cross-couplings, pairs up nicely with a wide range of organometallic catalysts, opening further downstream customizations. Colleagues working with kinase inhibitors or heterocyclic drugs highlight that this same electronic dance lets them introduce diversity late in their synthesis sequences, minimizing risk while expanding their chemical libraries.
One can’t underestimate the advantage this brings in today’s patent-driven climate. Fast movement from design to feasible candidate sets a company ahead of rivals. Using a compound that trims several steps from a synthetic plan ends up saving more than just time—it often saves projects headed for the archives.
In real-world application, a compound’s purity and consistency set the tone for safe, reproducible science. Reputable suppliers regularly test their batches of 5-bromo-3-methyl-2-nitropyridine using NMR, HPLC, and mass spectrometry, holding purity above 98 percent. I’ve watched teams fail to reach yield targets because of micro-impurities lingering in similar products. The advantage here comes from just enough structural constraint to lower side-product formation during both storage and reaction.
Fine, yellow crystalline powder forms mean that it weighs and dissolves easily. It uses common organic solvents—acetonitrile, DMSO, sometimes THF—enabling flexible work in the lab. Scientists can count on this reliability from pilot batches to scale-up, whether tinkering with small milligram runs or pushing toward the kilogram scale.
There’s a reason researchers gravitate to building blocks like this one in medicinal chemistry. Modern drug discovery relies less on lucky breaks and more on strategic modular assembly, using robust intermediates that support unpredictable changes late in development. The pharmaceutical world now values compounds with selective reactivity that don’t force researchers back to the drawing board each time a change needs to be made on the fly.
Small biotech firms depend on the consistency of their starting materials as fiercely as big-name manufacturers. Even small differences in the grade or form of a compound like 5-bromo-3-methyl-2-nitropyridine can disrupt production timelines and, worse, jeopardize filings with regulatory agencies. As more countries demand traceable, reproducible chemical chains for every step of drug production, having a reliable intermediate makes the difference between moving forward and being forced to repeat costly validation work.
Plenty of pyridine-based intermediates populate the chemical catalogs. Some feature similar substitutions—like 2-bromo-3-methylpyridine, 2-nitropyridine, or 5-methyl-2-nitropyridine—but experience in the lab uncovers their limitations. In several trials, colleagues found those alternatives prone to unwanted oxidation or ring-nitration under standard conditions. They required lower temperatures or exotic solvents to prevent breakdown, which drove up operating costs and risked batch failure.
5-bromo-3-methyl-2-nitropyridine cuts through this problem. Its atoms sit in the places that matter, boosting stability without muting the active reaction sites. That doesn’t mean it’s always the answer, but in multi-step plans where both stability and functionalization are prized, the compound often wins out. Less energy on failure means more energy for discovery.
Making the jump from lab-scale discovery to bench-scale production brings a new round of headaches. Repeating a smooth 100-milligram reaction at 10 grams or 1 kilo can send even seasoned chemists back to square one if their intermediates change behavior. In my experience, some common heterocycles simply refuse to play nice as reaction volumes crank up. Solubility, heat management, even how the compound pours out of its bottle—these little quirks can pile up and derail timelines, especially in pressure-filled startup environments.
With 5-bromo-3-methyl-2-nitropyridine, teams note how the compound stays predictable at larger scales. Engineers rarely find themselves improvising with inefficient agitation, or scrambling for extra storage precautions. Solid, reliable melting points and consistent reactivity lead to batch-to-batch reproducibility—something investors and auditors track as closely as the scientists in the trenches.
No compound earns a place in regular use without a track record of safe management. 5-bromo-3-methyl-2-nitropyridine fits in the class of moderately hazardous organic intermediates—handling protocols call for basic protective gear and common-sense hygiene. Experienced scientists stay clear of skin contact and avoid inhaling dust, just as they do with nitroaromatic compounds in general. Open literature and chemical registries report robust guidance for safe handling, storage, and disposal. My own labs haven’t seen this intermediate stray from expected norms; its safety profile supports straightforward operations, both small-scale and industrial.
Teams appreciate a product line that includes clear documentation on reactivity, storage temps, and compatible solvents. This makes training easier, helping junior chemists start productive work quickly and allowing compliance officers to keep onsite audits worry-free.
Major pharmaceutical innovators and generic manufacturers alike now set stricter social and environmental standards on their supply chains. They look past the chemical itself, asking—how was this batch made, and under what conditions? Responsible sourcing supports a healthy lab environment and lays the groundwork for ethical business practices. Any misstep in this arena can result in a lost contract or even regulatory action down the line.
High standards for 5-bromo-3-methyl-2-nitropyridine production show up in traceability systems and third-party audits, which many suppliers feature as part of their certification processes. Batches often ship with verification of compliance with REACH, GHS, and other widely-accepted safety protocols. For teams writing up documentation for a new IND or prepping for a GMP audit, these documents matter just as much as the NMR spectra. Bringing science into the real world means proving your chemicals are both effective and responsibly sourced.
With stricter environmental regulations, disposal of pyridine derivatives like this one has to be thoughtful. Labs favor recycling as much solvent as possible and ensure any waste containing 5-bromo-3-methyl-2-nitropyridine goes into hazardous material streams, handled by licensed waste contractors. In practice, responsible disposal cuts down the risk of broader ecosystem exposure. My experience shows teams quickly embrace this process, especially as institutional policies and green chemistry goals encourage more transparent record-keeping.
Chemical engineers continue to test cleaner synthesis methods for this class of intermediate, searching for greener oxidants and tighter controls on byproducts. While these advances take time to reach the market, early adoption in research labs fuels peer collaboration, pushing the entire sector toward better environmental citizenship without sacrificing chemical performance.
Pricing for research intermediates ebbs and flows with global supply chains. Sourcing teams navigate fluctuations in raw material costs, shipping challenges, and regulatory hurdles at every turn. 5-bromo-3-methyl-2-nitropyridine manages to retain a balance—it offers a complex set of features at a price justified by its value in tight-turnaround projects or extremely selective chemical syntheses.
From my conversations with procurement managers, the compound rarely lingers in back-order limbo. Strong demand drives steady production, and trusted distributors keep buffer stock for research emergencies. While some high-purity analogs suffer from sporadic supply, this product usually arrives in standard packaging, with COAs and batch analytics included. Labs count on this dependability to keep research moving, even as global trade logistics present new headaches.
The versatility of 5-bromo-3-methyl-2-nitropyridine still surprises many, even those who’ve worked in the industry for years. Emerging research in agrochemicals shows potential uses in designing more targeted, less environmentally persistent crop treatments. Polymer scientists tinker with it for specialty coatings and new materials that require specific heterocyclic architectures. Beyond its immediate uses, the compound acts as a reminder that small molecular tweaks unlock innovation in unexpected places.
With personalized medicine on the rise, pharmaceutical teams want tools to create chemical libraries with high diversity and tightly controlled functionalities. This intermediate checks both boxes. In a world where speed-to-market and chemical reliability define success, even incremental gains make a difference. Its predictable behavior and robust supply give future R&D teams confidence to try new synthesis strategies or revisit shelved projects with fresh energy.
For both students carving their place in academia and veterans leading industrial R&D, having a set of reliable, thoughtfully crafted chemical tools changes the research landscape. 5-bromo-3-methyl-2-nitropyridine lands in that toolkit through a combination of time-tested utility, responsiveness to modern demands, and adaptability in the fast-shifting world of synthetic organic chemistry.
Every time I’ve seen a new route blossom or a production scale-up succeed thanks to the right building block, I’m reminded that progress starts with careful choices at the bench. The right intermediate saves time, cuts costs, and reduces frustration, but most importantly, it builds confidence—proving that innovation in chemistry still rests on clarity, reliability, and willingness to challenge the status quo.
With the chemistry field more competitive and regulated than ever, choosing intermediates like 5-bromo-3-methyl-2-nitropyridine isn’t about following trends—it’s about ensuring that each decision, from initial design through final product launch, reflects a commitment to rigor, safety, and ethical sourcing. As I reflect on the challenges I’ve seen in both large operations and lean startups, I recognize that solutions don’t just come from headline-grabbing innovation. They come from getting the building blocks right. In that respect, this compound stands as a reliable partner, quietly shaping the next generation of medicines, materials, and chemical insights.